Guardant Health Stock Market Value
| GH Stock | USD 16.39 0.23 1.42% |
| Symbol | Guardant |
Guardant Health Price To Book Ratio
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Guardant Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Guardant Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Guardant Health.
| 03/19/2024 |
| 04/18/2024 |
If you would invest 0.00 in Guardant Health on March 19, 2024 and sell it all today you would earn a total of 0.00 from holding Guardant Health or generate 0.0% return on investment in Guardant Health over 30 days. Guardant Health is related to or competes with Illumina, Twist Bioscience, Myriad Genetics, Agilent Technologies, Thermo Fisher, and Danaher. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States... More
Guardant Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Guardant Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Guardant Health upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 22.73 | |||
| Value At Risk | (7.29) | |||
| Potential Upside | 5.82 |
Guardant Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Guardant Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Guardant Health's standard deviation. In reality, there are many statistical measures that can use Guardant Health historical prices to predict the future Guardant Health's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.61) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.25) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardant Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardant Health Backtested Returns
Guardant Health holds Efficiency (Sharpe) Ratio of -0.12, which attests that the entity had a -0.12% return per unit of standard deviation over the last 3 months. Guardant Health exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Guardant Health's market risk adjusted performance of (0.24), and Risk Adjusted Performance of (0.07) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.05, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Guardant Health will likely underperform. Guardant Health has an expected return of -0.47%. Please make sure to check out Guardant Health value at risk, rate of daily change, and the relationship between the total risk alpha and kurtosis , to decide if Guardant Health performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.72 |
Almost perfect reverse predictability
Guardant Health has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Guardant Health time series from 19th of March 2024 to 3rd of April 2024 and 3rd of April 2024 to 18th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Guardant Health price movement. The serial correlation of -0.72 indicates that around 72.0% of current Guardant Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.72 | |
| Spearman Rank Test | -0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 1.22 |
Guardant Health lagged returns against current returns
Autocorrelation, which is Guardant Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Guardant Health's stock expected returns. We can calculate the autocorrelation of Guardant Health returns to help us make a trade decision. For example, suppose you find that Guardant Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Guardant Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Guardant Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Guardant Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Guardant Health stock over time.
Current vs Lagged Prices |
| Timeline |
Guardant Health Lagged Returns
When evaluating Guardant Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Guardant Health stock have on its future price. Guardant Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Guardant Health autocorrelation shows the relationship between Guardant Health stock current value and its past values and can show if there is a momentum factor associated with investing in Guardant Health.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Guardant Health Correlation, Guardant Health Volatility and Guardant Health Alpha and Beta module to complement your research on Guardant Health. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Guardant Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.